TickerFactsScreenerDevelopers

OptimizeRx Corp (OPRX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $1.28M2011: $959.2K2012: $284.3K2013: $1.12M2014: $3.45M2015: $8.21M2016: $7.03M2017: $5.12M2018: $8.91M2019: $18.85M2020: $10.52M2021: $84.68M2022: $18.21M2023: $13.85M2024: $13.38M2025: $23.36M$23.36M
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$23.36M+74.6%
2024$13.38M-3.4%
2023$13.85M-23.9%
2022$18.21M-78.5%
2021$84.68M+705.2%
2020$10.52M-44.2%
2019$18.85M+111.5%
2018$8.91M+74.0%
2017$5.12M-27.2%
2016$7.03M-14.3%
2015$8.21M+138.1%
2014$3.45M+208.2%
2013$1.12M+293.4%
2012$284.3K-70.4%
2011$959.2K-25.0%
2010$1.28M—